The oligomeric form of amyloid-β peptide (Aβ42)
plays
a crucial role in the pathogenesis of Alzheimer’s disease (AD)
and is responsible for cognitive deficits. The soluble oligomers are
believed to be more toxic compared to the fibril form. Protein-L-isoaspartyl methyltransferase (PIMT) is a repair enzyme
that converts aberrant isoAsp residues, formed spontaneously on isomerization
of normal Asp and Asn residues, back to typical Asp. It was shown
to inhibit the fibrillization of Aβ42 (containing three Asp
residues), and here, we investigate its effect on the size, conformation,
and toxicity of Aβ42 oligomers (AβO). Far-UV CD indicated
a shift in the conformational feature of AβOs from the random
coil to β-sheet in the presence of PIMT. Binding of bis-ANS
to different AβOs (obtained using different concentrations of
Aβ42 monomer) indicated the correlation of size of oligomers
to hydrophobicity: the smallest AβO having the highest hydrophobicity
is the most toxic. Dynamic light scattering showed an increase in
size of AβO with the addition of PIMT, a contrasting role to
that on Aβ fibril. Assays using PC12-derived neurons showed
the neuroprotective role of PIMT against AβO-induced toxicity.
Furthermore, we have elaborated on the molecular mechanism of the
antifibrillar action of PIMT and how this function is correlated with
its enzymatic activity. PIMT has a more pronounced effect on AβO
as compared to a small heat shock protein, pointing to its importance
for the amelioration of the adverse effect of both Aβ42 oligomers
and fibrils.